Sunshine Biopharma (SBFM) Competitors $1.91 -0.09 (-4.50%) Closing price 03:59 PM EasternExtended Trading$2.04 +0.13 (+6.81%) As of 05:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SBFM vs. TRAW, APLM, PRPH, TXMD, GELS, KPRX, AIM, INDP, ACXP, and NEUPShould you be buying Sunshine Biopharma stock or one of its competitors? The main competitors of Sunshine Biopharma include Traws Pharma (TRAW), Apollomics (APLM), ProPhase Labs (PRPH), TherapeuticsMD (TXMD), Gelteq (GELS), Kiora Pharmaceuticals (KPRX), AIM ImmunoTech (AIM), Indaptus Therapeutics (INDP), Acurx Pharmaceuticals (ACXP), and Neuphoria Therapeutics Inc. - Common Stock (NEUP). These companies are all part of the "pharmaceutical products" industry. Sunshine Biopharma vs. Traws Pharma Apollomics ProPhase Labs TherapeuticsMD Gelteq Kiora Pharmaceuticals AIM ImmunoTech Indaptus Therapeutics Acurx Pharmaceuticals Neuphoria Therapeutics Inc. - Common Stock Sunshine Biopharma (NASDAQ:SBFM) and Traws Pharma (NASDAQ:TRAW) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment. Do analysts prefer SBFM or TRAW? Sunshine Biopharma presently has a consensus target price of $15.00, suggesting a potential upside of 685.34%. Given Sunshine Biopharma's stronger consensus rating and higher probable upside, research analysts plainly believe Sunshine Biopharma is more favorable than Traws Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sunshine Biopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Traws Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is SBFM or TRAW more profitable? Sunshine Biopharma has a net margin of -12.82% compared to Traws Pharma's net margin of -62,294.25%. Traws Pharma's return on equity of 0.00% beat Sunshine Biopharma's return on equity.Company Net Margins Return on Equity Return on Assets Sunshine Biopharma-12.82% -17.89% -14.25% Traws Pharma -62,294.25%N/A -822.38% Do institutionals & insiders hold more shares of SBFM or TRAW? 42.0% of Sunshine Biopharma shares are owned by institutional investors. Comparatively, 7.9% of Traws Pharma shares are owned by institutional investors. 0.1% of Sunshine Biopharma shares are owned by company insiders. Comparatively, 13.6% of Traws Pharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community favor SBFM or TRAW? Sunshine Biopharma received 2 more outperform votes than Traws Pharma when rated by MarketBeat users. CompanyUnderperformOutperformSunshine BiopharmaOutperform Votes2100.00% Underperform VotesNo VotesTraws PharmaN/AN/A Which has preferable earnings & valuation, SBFM or TRAW? Sunshine Biopharma has higher revenue and earnings than Traws Pharma. Traws Pharma is trading at a lower price-to-earnings ratio than Sunshine Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSunshine Biopharma$32.96M0.07-$4.51M-$150.88-0.01Traws Pharma$226K37.16-$18.95M-$141.56-0.02 Does the media refer more to SBFM or TRAW? In the previous week, Traws Pharma had 13 more articles in the media than Sunshine Biopharma. MarketBeat recorded 17 mentions for Traws Pharma and 4 mentions for Sunshine Biopharma. Sunshine Biopharma's average media sentiment score of 0.68 beat Traws Pharma's score of 0.23 indicating that Sunshine Biopharma is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sunshine Biopharma 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Traws Pharma 0 Very Positive mention(s) 2 Positive mention(s) 13 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk and volatility, SBFM or TRAW? Sunshine Biopharma has a beta of 1.35, indicating that its stock price is 35% more volatile than the S&P 500. Comparatively, Traws Pharma has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500. SummarySunshine Biopharma beats Traws Pharma on 11 of the 17 factors compared between the two stocks. Remove Ads Get Sunshine Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SBFM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SBFM vs. The Competition Export to ExcelMetricSunshine BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.34M$6.90B$5.64B$7.80BDividend YieldN/A2.80%5.34%4.03%P/E Ratio-0.017.4223.6318.68Price / Sales0.07206.91370.1089.74Price / CashN/A65.6738.1734.64Price / Book0.006.216.744.12Net Income-$4.51M$142.11M$3.20B$247.10M7 Day Performance-9.91%-8.90%-5.62%-3.82%1 Month Performance-16.59%-10.51%-0.37%-6.24%1 Year Performance-68.43%-12.80%7.73%-1.89% Sunshine Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SBFMSunshine Biopharma2.319 of 5 stars$1.91-4.5%$15.00+685.3%-66.9%$2.34M$32.96M-0.013Short Interest ↑News CoverageGap UpTRAWTraws Pharma1.1654 of 5 stars$2.84flatN/AN/A$10.37M$226,000.00-0.0217Earnings ReportUpcoming EarningsNews CoverageGap UpAPLMApollomics2.5333 of 5 stars$9.50-4.0%$200.00+2,005.3%-89.8%$10.33M$1.22M0.0045News CoveragePRPHProPhase Labs1.7417 of 5 stars$0.43+39.0%N/A-93.2%$10.25M$12.75M-0.34130Short Interest ↓News CoverageGap DownTXMDTherapeuticsMD0.8763 of 5 stars$0.87-2.8%N/A-57.1%$9.98M$1.60M0.00420Upcoming EarningsShort Interest ↓Gap DownGELSGelteqN/A$1.04-1.9%N/AN/A$9.82MN/A0.00N/AKPRXKiora Pharmaceuticals3.1808 of 5 stars$3.23-1.8%$10.00+209.6%-51.5%$9.69M$16M0.0010Earnings ReportAnalyst ForecastGap UpAIMAIM ImmunoTech1.8031 of 5 stars$0.14-1.1%$2.75+1,858.7%-74.3%$9.65M$190,000.00-0.3020INDPIndaptus Therapeutics3.5643 of 5 stars$0.66-8.4%$8.50+1,187.9%-73.7%$9.52MN/A-0.396High Trading VolumeACXPAcurx Pharmaceuticals3.4032 of 5 stars$0.43+1.8%$12.00+2,684.9%-83.3%$9.50MN/A-0.403Positive NewsNEUPNeuphoria Therapeutics Inc. - Common Stock1.932 of 5 stars$5.40+0.4%$21.00+288.9%N/A$9.49M$662,715.000.00N/APositive News Remove Ads Related Companies and Tools Related Companies TRAW Competitors APLM Competitors PRPH Competitors TXMD Competitors GELS Competitors KPRX Competitors AIM Competitors INDP Competitors ACXP Competitors NEUP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SBFM) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sunshine Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sunshine Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SBFM Stock Free SBFM Stock Alerts